A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)

Continuous daily sunitinib for recurrent glioblastoma

(2012) Teri Nguyen Kreisl et al.   JOURNAL OF NEURO-ONCOLOGY

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma

(2012) Edward Pan et al.   JOURNAL OF NEURO-ONCOLOGY

Generation of Functional Blood Vessels from a Single c-kit+ Adult Vascular Endothelial Stem Cell

(2012) Shentong Fang et al.   PLOS BIOLOGY

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors

(2011) Samuel A. Goldlust et al.   JOURNAL OF NEURO-ONCOLOGY

Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib--A Phase II Trial

(2011) M. E. Hegi et al.   MOLECULAR CANCER THERAPEUTICS

Cell Surface Receptors in Malignant Glioma

(2011) Yan Michael Li et al.   NEUROSURGERY

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

(2010) Martin J.B. Taphoorn et al.   EUROPEAN JOURNAL OF CANCER

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

(2010) B. Neyns et al.   JOURNAL OF NEURO-ONCOLOGY

Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

(2008) M. Hutterer et al.   CLINICAL CANCER RESEARCH

MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

(2008) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY